Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven in Rheumatoid Arthritis
NCT00412256Phase 3Completed
- Sponsor
- Humanis Klinikum Niederösterreich
- Start
- Sep 2004
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in rheumatoid arthritis (RA), sponsored by Humanis Klinikum Niederösterreich. Started Sep 2004; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00412256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412256.